Chiesi’s Digital Health team is tasked with broadening Chiesi’s offerings to patients beyond pharmacological/biological solutions. This enables the company to deliver impact across the patient journey, focusing on improving outcomes through behavioral interventions in addition to the medications in our portfolio.
We actively seek opportunities to create patient impact and business value for our three franchises - AIR, CARE and RARE - through digital health offerings. We leverage a first-principles approach grounded in execution, a focus on science and evidence, and a quality-over-quantity mindset that prioritizes opportunities with quantifiable value for both patients and our business.
We collaborate closely with our three franchises at both the global and country levels in three stages: